Adult vaccines 2023-2024
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30123D16732
- Awardee
-
VBI Vaccines (Delaware) Inc. UEI FKYXJCJ2BKC3
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- 2023 Vaccines for Adults (VFA) Solicitation · 75D30123R72732 · Posted Apr 5, 2023
- Last date to order 100% complete
- IDV ceiling
- $25,350,000.00
- Maximum order
- $25,350,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Centers for Disease Control and Prevention (CDC) awarded a multiple-award indefinite delivery contract valued at $25.35 million to VBI Vaccines (Delaware) Inc. under a civilian federal contract vehicle. The contract, effective from July 1, 2023 through June 30, 2024, procures a comprehensive portfolio of adult vaccines including hepatitis A and B formulations, pneumococcal vaccines (polysaccharide and conjugate), tetanus and diphtheria toxoids, herpes zoster, measles/mumps/rubella, meningococcal conjugate and serogroup B, human papillomavirus, and varicella vaccines. The solicitation, issued April 5, 2023 with proposals due April 19, 2023, specified estimated quantities of 1.5 to 3 million doses across the 12 vaccine types, with minimum and maximum order quantities established for each product line.
The vaccines procured under this contract directly support CDC-administered immunization programs delivered through state health departments to adult populations. VBI Vaccines, a foreign-owned for-profit vaccine manufacturer and developer, fulfills this role as a prime contractor with performance to be executed within the United States. This single-award contract was competitively solicited with no set-aside designation, enabling the CDC to establish an indefinite delivery vehicle for reliable vaccine supply chain management across its adult immunization portfolio during the specified period of performance.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$142,298 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $294,398 |
Quick answers
Who was awarded contract 75D30123D16732?
75D30123D16732 was awarded to VBI Vaccines (Delaware) Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on July 1, 2023.
How much is contract 75D30123D16732 worth?
75D30123D16732's own ceiling is $25,350,000. A single order can be worth up to $25,350,000.
Who can order from contract 75D30123D16732?
75D30123D16732 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30123D16732 competed?
The extent of competition for 75D30123D16732 was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV